Chapter 58
Early Medical and Surgical Complications After Kidney Transplantation
Wai H. Lim,
Henry Pleass,
Wai H. Lim
Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Australia
School of Medicine, Discipline of Internal Medicine University of Western Australia, Perth, Australia
Search for more papers by this authorHenry Pleass
Specialty of Surgery, Faculty of Medicine and Health, University of Sydney
Centre for Transplant and Renal Research, Westmead Hospital, Sydney, Australia
Department of Surgery, Surgical Research and Education Centre, Westmead Hospital, Sydney, Australia
Search for more papers by this authorWai H. Lim,
Henry Pleass,
Wai H. Lim
Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Australia
School of Medicine, Discipline of Internal Medicine University of Western Australia, Perth, Australia
Search for more papers by this authorHenry Pleass
Specialty of Surgery, Faculty of Medicine and Health, University of Sydney
Centre for Transplant and Renal Research, Westmead Hospital, Sydney, Australia
Department of Surgery, Surgical Research and Education Centre, Westmead Hospital, Sydney, Australia
Search for more papers by this authorBook Editor(s):Jonathan C. Craig MBChB, DipCH, MMed(Clin Epi), PhD, FAHMS,
Donald A. Molony MD,
Giovanni F.M. Strippoli MD, PhD, MPH, MM (Epi),
Jonathan C. Craig MBChB, DipCH, MMed(Clin Epi), PhD, FAHMS
Matthew Flinders Distinguished Professor Vice President and Executive Dean
College of Medicine and Public Health, Flinders University, Adelaide, Australia
Search for more papers by this authorDonald A. Molony MD
Professor of Medicine Distinguished Teaching Professor of the University of Texas System
Division of Renal Diseases and Hypertension AND Center for Clinical Research and Evidence-based Medicine, McGovern Medical School University of Texas, Houston, TX, USA
Search for more papers by this authorGiovanni F.M. Strippoli MD, PhD, MPH, MM (Epi)
Professor of Nephrology Adjunct Professor of Epidemiology
Department of Emergency and Organ Transplantation – University of Bari, Bari, Italy
School of Public Health, University of Sydney, Sydney, NSW, Australia
Search for more papers by this authorFirst published: 18 November 2022
Summary
Kidney transplantation is the treatment of choice in patients with end-stage kidney disease because it confers a significant survival advantage compared to dialysis treatment. This chapter discusses the short-term medical and surgical complications that can potentially cause allograft failure within one year post kidney transplantation, focusing on the practical approach, investigations, and treatment of these complications. The chapter presents the potential surgical and medical complications occurring in the first 12 months after kidney transplantation. The incidence of ureteric complications after kidney transplantation is estimated at between 2% and 12%, predominantly related to urine leak and obstruction. Acute rejection of the kidney allografts following transplantation continues to be a major impediment to long-term allograft survival. Delayed graft function is a common complication after kidney transplantation, with the highest incidence observed after donation after circulatory death kidney transplants.
References
- Wolfe , R.A. , Ashby , V.B. , Milford , E.L. et al. ( 1999 ). Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant . N. Engl. J. Med. 341 ( 23 ): 1725 – 1730 .
- Meier-Kriesche , H.U. , Ojo , A.O. , Port , F.K. et al. ( 2001 ). Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients . J. Am. Soc. Nephrol. 12 ( 1296 ): 1293 – 1296 .
- Arend , S.M. , Mallat , M.J. , Westendorp , R.J. et al. ( 1997 ). Patient survival after renal transplantation; more than 25 years follow-up . Nephrol. Dial. Transplant. 12 ( 8 ): 1672 – 1679 .
- Hariharan , S. , Johnson , C.P. , Bresnahan , B.A. et al. ( 2000 ). Improved graft survival after renal transplantation in the United States, 1988 to 1996 . N. Engl. J. Med. 342 ( 9 ): 605 – 612 .
- Halloran , P.F. ( 2004 ). Immunosuppressive drugs for kidney transplantation . N. Engl. J. Med. 351 ( 26 ): 2715 – 2229 .
- Tait , B.D. ( 2016 ). Detection of HLA antibodies in organ transplant recipients – triumphs and challenges of the solid phase bead assay . Front. Immunol. 7 : 570 .
- Konvalinka , A. and Tinckam , K. ( 2015 ). Utility of HLA antibody testing in kidney transplantation . J. Am. Soc. Nephrol. 26 ( 7 ): 1489 – 1502 .
- Lim , W.H. , Wong , G. , Heidt , S. , and Claas , F.H.J. ( 2018 ). Novel aspects of epitope matching and practical application in kidney transplantation . Kidney Int. 93 ( 2 ): 314 – 324 .
- Keddis , M.T. , El Ters , M. , Rodrigo , E. et al. ( 2014 ). Enhanced posttransplant management of patients with diabetes improves patient outcomes . Kidney Int. 86 ( 3 ): 610 – 618 .
- Young , J.B. , Neumayer , H.H. , and Gordon , R.D. ( 2010 ). Pretransplant cardiovascular evaluation and posttransplant cardiovascular risk . Kidney Int. Suppl. ( 118 ): S1 – S7 .
- Pilmore , H. , Dent , H. , Chang , S. et al. ( 2010 ). Reduction in cardiovascular death after kidney transplantation . Transplantation 89 ( 7 ): 851 – 857 .
- Gill , J.S. and Pereira , B.J. ( 2003 ). Death in the first year after kidney transplantation: implications for patients on the transplant waiting list . Transplantation 75 ( 1 ): 113 – 117 .
- Farrugia , D. , Cheshire , J. , Begaj , I. et al. ( 2014 ). Death within the first year after kidney transplantation–an observational cohort study . Transpl. Int. 27 ( 3 ): 262 – 270 .
- Ma , M.K. , Lim , W.H. , Craig , J.C. et al. ( 2016 ). Mortality among younger and older recipients of kidney transplants from expanded criteria donors compared with standard criteria donors . Clin. J. Am. Soc. Nephrol. 11 ( 1 ): 128 – 136 .
- Lim , W.H. , Clayton , P. , Wong , G. et al. ( 2013 ). Outcomes of kidney transplantation from older living donors . Transplantation 95 ( 1 ): 106 – 113 .
- Chadban , S. , McDonald , S. , Excell , L. et al. ( 2005 ). Chapter 8: Transplantation . pages 103-124. ANZDATA Registry Report 2005. Australia and New Zealand Dialysis and Transplant Registry. Adelaide, South Australia, Australia .
- ANZDATA Registry . 40th Report, Chapter 7: Transplantation. Pages 1-20. Australia and New Zealand Dialysis and Transplant Registry , Adelaide, Australia . 2018. Available at: http://www.anzdata.org.au
- United States Renal Data System . ( 2017 ). USRDS Annual data report: Epidemiology of kidney disease in the United States . Bethesda, MD : National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases .
- Canadian Institute for Health Information ( 2016 ). CORR Annual Statistics, 2007–2016 . https://www.cihi.ca/en/corr-annual-statistics-2007-to-2016 (accessed 04 September 2018).
- Pyart , R. , Wong , E. , Sharples , E. et al. ( 2018 ). UK renal registry 20th annual report. Chapter 3: Demographic and biochemistry profile of kidney transplant recipients in the UK in 2016: national and centre-specific analyses . Nephron 139 ( Suppl1 ): 75 – 104 .
- Ravanan , R. , Udayaraj , U. , Bakran , A. et al. ( 2007 ). Measures of care in adult renal transplant recipients in the United Kingdom (chapter 11) . Nephrol Dial Transplant 22 Suppl 7 : vii138 – 154 .
- Sellares , J. , de Freitas , D.G. , Mengel , M. et al. ( 2012 ). Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence . Am. J. Transplant. 12 ( 2 ): 388 – 399 .
- Morales , J.M. , Marcen , R. , del Castillo , D. et al. ( 2012 ). Risk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multicentre study . Nephrol. Dial. Transplant. 27 ( Suppl 4 ): iv39 – iv46 .
- Meier-Kriesche , H.U. , Schold , J.D. , Srinivas , T.R. , and Kaplan , B. ( 2004 ). Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era . Am. J. Transplant. 4 ( 3 ): 378 – 383 .
- Lamb , K.E. , Lodhi , S. , and Meier-Kriesche , H.U. ( 2011 ). Long-term renal allograft survival in the United States: a critical reappraisal . Am. J. Transplant. 11 ( 3 ): 450 – 462 .
- Coemans , M. , Susal , C. , Dohler , B. et al. ( 2018 ). Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015 . Kidney Int 94 ( 5 ): 964 – 973 .
- Russ , G.R. ( 2013 ). Optimising the use of mTOR inhibitors in renal transplantation . Transplant. Res. 2 ( Suppl 1 ): S4 .
- Langer , R.M. and Kahan , B.D. ( 2002 ). Alexis Carrel's legacy: visionary of vascular surgery and organ transplantation . Transplant. Proc. 34 ( 4 ): 1061 – 1066 .
- Tran , M.H. , Foster , C.E. , Kalantar-Zadeh , K. , and Ichii , H. ( 2016 ). Kidney transplantation in obese patients . World J. Transplant. 6 ( 1 ): 135 – 143 .
- Lucewicz , A. , Isaacs , A. , Allen , R.D. et al. ( 2012 ). Torsion of intraperitoneal kidney transplant . ANZ J. Surg. 82 ( 5 ): 299 – 302 .
- Chung , H. , Lam , V.W. , Yuen , L.P. et al. ( 2015 ). Renal transplantation: better fat than thin . J. Surg. Res. 194 ( 2 ): 644 – 652 .
- Modi , P. , Pal , B. , Modi , J. et al. ( 2013 ). Retroperitoneoscopic living-donor nephrectomy and laparoscopic kidney transplantation: experience of initial 72 cases . Transplantation 95 ( 1 ): 100 – 105 .
- Ponticelli , C. , Moia , M. , and Montagnino , G. ( 2009 ). Renal allograft thrombosis . Nephrol. Dial. Transplant. 24 ( 5 ): 1388 – 1393 .
- El Zorkany , K. , Bridson , J.M. , Sharma , A. , and Halawa , A. ( 2017 ). Transplant renal vein thrombosis . Exp. Clin. Transplant. 15 ( 2 ): 123 – 129 .
- Jones , R. , Murie , J. , Ting , A. et al. ( 1988 ). Renal vascular thrombosis of cadaveric renal allografts in patients receiving cyclosporin, azathioprine and prednisolone triple therapy . Clin. Transpl. 2 : 122 – 126 .
- Smith , J.M. , Stablein , D. , Singh , A. et al. ( 2006 ). Decreased risk of renal allograft thrombosis associated with interleukin-2 receptor antagonists: a report of the NAPRTCS . Am. J. Transplant. 6 ( 3 ): 585 – 588 .
- Vacher-Coponat , H. , McDonald , S. , Clayton , P. et al. ( 2013 ). Inferior early posttransplant outcomes for recipients of right versus left deceased donor kidneys: an ANZDATA registry analysis . Am. J. Transplant. 13 ( 2 ): 399 – 405 .
- Corbett , C. , Armstrong , M.J. , and Neuberger , J. ( 2012 ). Tobacco smoking and solid organ transplantation . Transplantation 94 ( 10 ): 979 – 987 .
- Nicholson , M.L. , Yong , C. , Trotter , P.B. et al. ( 2019 ). Risk factors for transplant renal artery stenosis after live donor transplantation . Br. J. Surg 106 ( 3 ): 199 – 205 .
- Gondalia , R. , Vernuccio , F. , Marin , D. , and Bashir , M.R. ( 2018 ). The role of MR imaging in the assessment of renal allograft vasculature . Abdom. Radiol. (NY) 43 ( 10 ): 2589 – 2296 .
- Lim , W.H. , Coates , P.T. , Russ , G.R. et al. ( 2019 ). Weekend effect on early allograft outcome after kidney transplantation- a multi-Centre cohort study . Transpl. Int 32 ( 4 ): 387 – 398 .
-
Lee , G.
,
Barlow , A.
,
Doughman , T.
, and
Nicholson , M.L.
(
2014
).
External iliac artery dissection causing early renal transplant dysfunction
.
BMJ Case Rep.
2014
; 2014: bcr2014204160.
10.1136/bcr-2014-204160 Google Scholar
- Saito , M. , Satoh , S. , Tsuchiya , N. et al. ( 2004 ). Angioplasty for the intimal dissection of graft artery immediately after blood reflow: a successful case of renal transplantation . Hinyokika Kiyo 50 ( 3 ): 195 – 198 .
- Patrono , D. , Verhelst , R. , Buemi , A. et al. ( 2015 ). Presentation and management of mycotic pseudoaneurysm after kidney transplantation . Transpl. Infect. Dis. 17 ( 1 ): 129 – 136 .
- Mai , H. , Champion , L. , Ouali , N. et al. ( 2006 ). Candida albicans arteritis transmitted by conservative liquid after renal transplantation: a report of four cases and review of the literature . Transplantation 82 ( 9 ): 1163 – 1167 .
- Minz , M. , Sharma , A. , Kumar , S. et al. ( 2011 ). Use of autogenous internal iliac artery for bridging the external iliac artery after excision of Aspergillus mycotic aneurysm in renal transplant recipients . J. Vasc. Surg. 53 ( 3 ): 802 – 804 .
- Hameed , A.M. , Pleass , H.C. , Wong , G. , and Hawthorne , W.J. ( 2016 ). Maximizing kidneys for transplantation using machine perfusion: from the past to the future: a comprehensive systematic review and meta-analysis . Medicine (Baltimore) 95 ( 40 ): e5083 .
- Lacaze , P. , Millis , N. , Fookes , M. et al. ( 2017 ). Rare disease registries: a call to action . Intern. Med. J. 47 ( 9 ): 1075 – 1079 .
- Heylen , L. , Naesens , M. , Jochmans , I. et al. ( 2015 ). The effect of anastomosis time on outcome in recipients of kidneys donated after brain death: a cohort study . Am. J. Transplant. 15 ( 11 ): 2900 – 2907 .
- Hameed , A.M. , Yao , J. , Allen , R.D.M. et al. ( 2018 ). The evolution of kidney transplantation surgery into the robotic era and its prospects for obese recipients . Transplantation 102 ( 10 ): 1650 – 1665 .
- Suttle , T. , Fumo , D. , Baghmanli , Z. et al. ( 2016 ). Comparison of urologic complications between ureteroneocystostomy and ureteroureterostomy in renal transplant: a meta-analysis . Exp. Clin. Transplant. 14 ( 3 ): 276 – 281 .
- Pleass , H.C. , Clark , K.R. , Rigg , K.M. et al. ( 1995 ). Urologic complications after renal transplantation: a prospective randomized trial comparing different techniques of ureteric anastomosis and the use of prophylactic ureteric stents . Transplant. Proc. 27 ( 1 ): 1091 – 1092 .
- Wilson , C.H. , Rix , D.A. , and Manas , D.M. ( 2013 ). Routine intraoperative ureteric stenting for kidney transplant recipients . Cochrane Database Syst. Rev. ( 6 ): CD004925.
- Ambalathingal , G.R. , Francis , R.S. , Smyth , M.J. et al. ( 2017 ). BK polyomavirus: clinical aspects, immune regulation, and emerging therapies . Clin. Microbiol. Rev. 30 ( 2 ): 503 – 528 .
- Alberts , V.P. , Idu , M.M. , Legemate , D.A. et al. ( 2014 ). Ureterovesical anastomotic techniques for kidney transplantation: a systematic review and meta-analysis . Transpl. Int. 27 ( 6 ): 593 – 605 .
- Thompson , E.R. , Hosgood , S.A. , Nicholson , M.L. , and Wilson , C.H. ( 2018 ). Early versus late ureteric stent removal after kidney transplantation . Cochrane Database Syst. Rev. 1 : CD011455.
- Buttigieg , J. , Agius-Anastasi , A. , Sharma , A. , and Halawa , A. ( 2018 ). Early urological complications after kidney transplantation: an overview . World J. Transplant. 8 ( 5 ): 142 – 149 .
- Boonjindasup , A. , Smith , A. , Paramesh , A. et al. ( 2016 ). A rationale to use bladder boari flap reconstruction for late kidney transplant ureteral strictures . Urology 89 : 144 – 149 .
- Lucewicz , A. , Wong , G. , Lam , V.W. et al. ( 2011 ). Management of primary symptomatic lymphocele after kidney transplantation: a systematic review . Transplantation 92 ( 6 ): 663 – 673 .
- Nashan , B. and Citterio , F. ( 2012 ). Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation: a critical review of the literature . Transplantation 94 ( 6 ): 547 – 561 .
- Veasey , T.M. , Fleming , J.N. , Strout , S.E. et al. ( 2018 ). Morbid obesity and functional status as predictors of surgical complication after renal transplantation . Am. J. Surg. 215 ( 4 ): 663 – 668 .
- Smith , C.T. , Katz , M.G. , Foley , D. et al. ( 2015 ). Incidence and risk factors of incisional hernia formation following abdominal organ transplantation . Surg. Endosc. 29 ( 2 ): 398 – 404 .
- McDonald , S. , Russ , G. , Campbell , S. , and Chadban , S. ( 2007 ). Kidney transplant rejection in Australia and New Zealand: relationships between rejection and graft outcome . Am. J. Transplant. 7 ( 5 ): 1201 – 1208 .
- Burton , H. , Iyamu Perisanidou , L. , Steenkamp , R. et al. ( 2018 ). Causes of renal allograft failure in the UK: trends in UK Renal Registry and National Health Service Blood and Transplant data from 2000 to 2013 . Nephrol. Dial. Transplant .
- Lefaucheur , C. , Loupy , A. , Vernerey , D. et al. ( 2013 ). Antibody-mediated vascular rejection of kidney allografts: a population-based study . Lancet 381 ( 9863 ): 313 – 319 .
- Teo , R.Z. , Wong , G. , Russ , G.R. , and Lim , W.H. ( 2016 ). Cell-mediated and humoral acute vascular rejection and graft loss: a registry study . Nephrology (Carlton) 21 ( 2 ): 147 – 155 .
- Wan , S.S. , Ying , T.D. , Wyburn , K. et al. ( 2018 ). The treatment of antibody-mediated rejection in kidney transplantation: an updated systematic review and meta-analysis . Transplantation 102 ( 4 ): 557 – 568 .
- Lamarche , C. , Cote , J.M. , Senecal , L. , and Cardinal , H. ( 2016 ). Efficacy of acute cellular rejection treatment according to Banff score in kidney transplant recipients: a systematic review . Transplant. Direct 2 ( 12 ): e115 .
- Webster , A. , Pankhurst , T. , Rinaldi , F. et al. ( 2006 ). Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients . Cochrane Database Syst. Rev. ( 2 ): CD004756.
- Webster , A.C. , Pankhurst , T. , Rinaldi , F. et al. ( 2006 ). Monoclonal and polyclonal antibody therapy for treating acute rejection in kidney transplant recipients: a systematic review of randomized trial data . Transplantation 81 ( 7 ): 953 – 965 .
- van den Hoogen , M.W. , Hesselink , D.A. , van Son , W.J. et al. ( 2013 ). Treatment of steroid-resistant acute renal allograft rejection with alemtuzumab . Am. J. Transplant. 13 ( 1 ): 192 – 196 .
- Webster , A.C. , Wu , S. , Tallapragada , K. et al. ( 2017 ). Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients . Cochrane Database Syst. Rev. 7 : CD004756.
- Lefaucheur , C. , Loupy , A. , Hill , G.S. et al. ( 2010 ). Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation . J. Am. Soc. Nephrol. 21 ( 8 ): 1398 – 1406 .
- Michielsen , L.A. , van Zuilen , A.D. , Krebber , M.M. et al. ( 2016 ). Clinical value of non-HLA antibodies in kidney transplantation: still an enigma? Transplant. Rev. (Orlando) 30 ( 4 ): 195 – 202 .
- Zhang , Q. and Reed , E.F. ( 2016 ). The importance of non-HLA antibodies in transplantation . Nat. Rev. Nephrol. 12 ( 8 ): 484 – 495 .
- Tinckam , K.J. and Chandraker , A. ( 2006 ). Mechanisms and role of HLA and non-HLA alloantibodies . Clin. J. Am. Soc. Nephrol. 1 ( 3 ): 404 – 414 .
- Dragun , D. , Muller , D.N. , Brasen , J.H. et al. ( 2005 ). Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection . N. Engl. J. Med. 352 ( 6 ): 558 – 569 .
- Genberg , H. , Kumlien , G. , Wennberg , L. , and Tyden , G. ( 2010 ). Isoagglutinin adsorption in ABO-incompatible transplantation . Transfus. Apher. Sci. 43 ( 2 ): 231 – 235 .
- de Weerd , A.E. and Betjes , M.G.H. ( 2018 ). ABO-incompatible kidney transplant outcomes: a meta-analysis . Clin. J. Am. Soc. Nephrol. 13 ( 8 ): 1234 – 1243 .
- Lo , P. , Sharma , A. , Craig , J.C. et al. ( 2016 ). Preconditioning therapy in ABO-incompatible living kidney transplantation: a systematic review and meta-analysis . Transplantation 100 ( 4 ): 933 – 942 .
- Ishida , H. , Kondo , T. , Shimizu , T. et al. ( 2015 ). Postoperative rebound of antiblood type antibodies and antibody-mediated rejection after ABO-incompatible living-related kidney transplantation . Transpl. Int. 28 ( 3 ): 286 – 296 .
- Chung , B.H. , Lim , J.U. , Kim , Y. et al. ( 2013 ). Impact of the baseline anti-A/B antibody titer on the clinical outcome in ABO-incompatible kidney transplantation . Nephron. Clin. Pract. 124 ( 1–2 ): 79 – 88 .
- Baek , C.H. , Kim , H. , Yang , W.S. et al. ( 2019 ). Clinical significance of isoagglutinin titer with the current desensitization protocol in ABO-incompatible kidney transplantation . Nephrology (Carlton) 24 ( 6 ): 654 – 660 .
- Sorensen , J.B. , Grant , W.J. , Belnap , L.P. et al. ( 2001 ). Transplantation of ABO group A2 kidneys from living donors into group O and B recipients . Am. J. Transplant. 1 ( 3 ): 296 – 299 .
- Zschiedrich , S. , Janigen , B. , Dimova , D. et al. ( 2016 ). One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-centre experience . Nephrol. Dial. Transplant. 31 ( 4 ): 663 – 671 .
- Morath , C. , Zeier , M. , and Susal , C. ( 2017 ). Increased risk of infection-associated death with incompatible kidney transplantations . Transpl. Int. 30 ( 12 ): 1209 – 1211 .
- Chung , B.H. , Joo , Y.Y. , Lee , J. et al. ( 2015 ). Impact of ABO incompatibility on the development of acute antibody-mediated rejection in kidney transplant recipients presensitized to HLA . PLoS One 10 ( 4 ): e0123638 .
- Ashimine , S. , Watarai , Y. , Yamamoto , T. et al. ( 2014 ). Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation . Kidney Int. 85 ( 2 ): 425 – 430 .
- Lim , W.H. , Chapman , J.R. , and Wong , G. ( 2015 ). Peak panel reactive antibody, cancer, graft, and patient outcomes in kidney transplant recipients . Transplantation 99 ( 5 ): 1043 – 1050 .
- Montgomery , R.A. , Lonze , B.E. , King , K.E. et al. ( 2011 ). Desensitization in HLA-incompatible kidney recipients and survival . N. Engl. J. Med. 365 ( 4 ): 318 – 326 .
- Bentall , A. , Cornell , L.D. , Gloor , J.M. et al. ( 2013 ). Five-year outcomes in living donor kidney transplants with a positive crossmatch . Am. J. Transplant. 13 ( 1 ): 76 – 85 .
- Gloor , J.M. , DeGoey , S.R. , Pineda , A.A. et al. ( 2003 ). Overcoming a positive crossmatch in living-donor kidney transplantation . Am. J. Transplant. 3 ( 8 ): 1017 – 1023 .
- Vo , A.A. , Choi , J. , Cisneros , K. et al. ( 2014 ). Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipients . Transplantation 98 ( 3 ): 312 – 319 .
- Vo , A.A. , Lukovsky , M. , Toyoda , M. et al. ( 2008 ). Rituximab and intravenous immune globulin for desensitization during renal transplantation . N. Engl. J. Med. 359 ( 3 ): 242 – 251 .
- Jordan , S.C. , Lorant , T. , Choi , J. et al. ( 2017 ). IgG endopeptidase in highly sensitized patients undergoing transplantation . N. Engl. J. Med. 377 ( 5 ): 442 – 453 .
- Duquesnoy , R.J. ( 2017 ). Are we ready for epitope-based HLA matching in clinical organ transplantation? Transplantation 101 ( 8 ): 1755 – 1765 .
- Duquesnoy , R.J. ( 2017 ). Should epitope-based HLA compatibility be used in the kidney allocation system? Human Immunol. 78 ( 1 ): 24 – 29 .
- Wiebe , C. , Pochinco , D. , Blydt-Hansen , T.D. et al. ( 2013 ). Class II HLA epitope matching-a strategy to minimize de novo donor-specific antibody development and improve outcomes . Am. J. Transplant. 13 ( 12 ): 3114 – 3122 .
- Wiebe , C. , Rush , D.N. , Nevins , T.E. et al. ( 2017 ). Class II eplet mismatch modulates tacrolimus trough levels required to prevent donor-specific antibody development . J. Am. Soc. Nephrol. 28 ( 11 ): 3353 – 3362 .
- Sapir-Pichhadze , R. , Tinckam , K. , Quach , K. et al. ( 2015 ). HLA-DR and -DQ eplet mismatches and transplant glomerulopathy: a nested case-control study . Am. J. Transplant. 15 ( 1 ): 137 – 148 .
- Heidt , S. , Witvliet , M.D. , Haasnoot , G.W. , and Claas , F.H. ( 2015 ). The 25th anniversary of the Eurotransplant Acceptable Mismatch program for highly sensitized patients . Transpl. Immunol. 33 ( 2 ): 51 – 57 .
- Sypek , M.P. , Alexander , S.I. , Cantwell , L. et al. ( 2017 ). Optimizing outcomes in pediatric renal transplantation through the Australian paired kidney exchange program . Am. J. Transplant. 17 ( 2 ): 534 – 541 .
- Brennan , D.C. , Daller , J.A. , Lake , K.D. et al. ( 2006 ). Rabbit antithymocyte globulin versus basiliximab in renal transplantation . N. Engl. J. Med. 355 ( 19 ): 1967 – 1977 .
- Thomusch , O. , Wiesener , M. , Opgenoorth , M. et al. ( 2016 ). Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (harmony): an open-label, multicentre, randomised controlled trial . Lancet 388 ( 10063 ): 3006 – 3016 .
- Haynes , R. , Harden , P. , Judge , P. et al. ( 2014 ). Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial . Lancet 384 ( 9955 ): 1684 – 1690 .
- Ekberg , H. , Tedesco-Silva , H. , Demirbas , A. et al. ( 2007 ). Reduced exposure to calcineurin inhibitors in renal transplantation . N. Engl. J. Med. 357 ( 25 ): 2562 – 2575 .
- Vincenti , F. , Charpentier , B. , Vanrenterghem , Y. et al. ( 2010 ). A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study) . Am. J. Transplant. 10 ( 3 ): 535 – 546 .
- Durrbach , A. , Pestana , J.M. , Pearson , T. et al. ( 2010 ). A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study) . Am. J. Transplant. 10 ( 3 ): 547 – 557 .
- Russ , G.R. , Tedesco-Silva , H. , Kuypers , D.R. et al. ( 2013 ). Efficacy of sotrastaurin plus tacrolimus after de novo kidney transplantation: randomized, phase II trial results . Am. J. Transplant. 13 ( 7 ): 1746 – 1756 .
- Tedesco-Silva , H. , Kho , M.M. , Hartmann , A. et al. ( 2013 ). Sotrastaurin in calcineurin inhibitor-free regimen using everolimus in de novo kidney transplant recipients . Am. J. Transplant. 13 ( 7 ): 1757 – 1768 .
- Lebranchu , Y. , Thierry , A. , Toupance , O. et al. ( 2009 ). Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study . Am. J. Transplant. 9 ( 5 ): 1115 – 1123 .
- Weir , M.R. , Mulgaonkar , S. , Chan , L. et al. ( 2011 ). Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial . Kidney Int. 79 ( 8 ): 897 – 907 .
- Tedesco Silva , H. Jr. , Cibrik , D. , Johnston , T. et al. ( 2010 ). Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients . Am. J. Transplant. 10 ( 6 ): 1401 – 1413 .
- Flechner , S.M. , Glyda , M. , Cockfield , S. et al. ( 2011 ). The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients . Am. J. Transplant. 11 ( 8 ): 1633 – 1644 .
- Pascual , J. , Berger , S.P. , Witzke , O. et al. ( 2018 ). Everolimus with reduced calcineurin inhibitor exposure in renal transplantation . J. Am. Soc. Nephrol. 29 ( 7 ): 1979 – 1991 .
- Siedlecki , A. , Irish , W. , and Brennan , D.C. ( 2011 ). Delayed graft function in the kidney transplant . Am. J. Transplant. 11 ( 11 ): 2279 – 2296 .
- Ponticelli , C. ( 2014 ). Ischaemia-reperfusion injury: a major protagonist in kidney transplantation . Nephrol. Dial. Transplant. 29 ( 6 ): 1134 – 1140 .
- Mangino , M.J. , Ametani , M. , Szabo , C. , and Southard , J.H. ( 2004 ). Poly(ADP-ribose) polymerase and renal hypothermic preservation injury . Am. J. Physiol. Renal Physiol. 286 ( 5 ): F838 – F847 .
- Belzer , F.O. and Southard , J.H. ( 1988 ). Principles of solid-organ preservation by cold storage . Transplantation 45 ( 4 ): 673 – 676 .
- Othman , M.M. , Ismael , A.Z. , and Hammouda , G.E. ( 2010 ). The impact of timing of maximal crystalloid hydration on early graft function during kidney transplantation . Anaesth. Analg. 110 ( 5 ): 1440 – 1446 .
- Stevens , L.A. , Schmid , C.H. , Greene , T. et al. ( 2009 ). Factors other than glomerular filtration rate affect serum cystatin C levels . Kidney Int. 75 ( 6 ): 652 – 660 .
- Wight , J.P. , Chilcott , J.B. , Holmes , M.W. , and Brewer , N. ( 2003 ). Pulsatile machine perfusion vs. cold storage of kidneys for transplantation: a rapid and systematic review . Clin. Transplant. 17 ( 4 ): 293 – 307 .
- Maltzman , J.S. and Haase , V.H. ( 2008 ). Low oxygen stimulates the immune system . Kidney Int. 73 ( 7 ): 797 – 799 .
- Cherukuri , A. , Mehta , R. , Sood , P. et al ( 2018 ). Early allograft inflammation and scarring associate with graft dysfunction and poor outcomes in renal transplant recipients with delayed graft function: a prospective single center cohort study . Transplant Int 31 ( 12 ): 1369 – 1379 .
- Mallon , D.H. , Summers , D.M. , Bradley , J.A. , and Pettigrew , G.J. ( 2013 ). Defining delayed graft function after renal transplantation: simplest is best . Transplantation 96 ( 10 ): 885 – 889 .
- Hall , I.E. , Reese , P.P. , Doshi , M.D. et al. ( 2017 ). Delayed graft function phenotypes and 12-month kidney transplant outcomes . Transplantation 101 ( 8 ): 1913 – 1923 .
- Giral-Classe , M. , Hourmant , M. , Cantarovich , D. et al. ( 1998 ). Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys . Kidney Int. 54 ( 3 ): 972 – 978 .
- de Sandes-Freitas , T.V. , Felipe , C.R. , Aguiar , W.F. et al. ( 2015 ). Prolonged delayed graft function is associated with inferior patient and kidney allograft survivals . PLoS One 10 ( 12 ): e0144188 .
- Lim , W.H. , Johnson , D.W. , Teixeira-Pinto , A. , and Wong , G. ( 2019 ). Association between duration of delayed graft function, acute rejection and allograft outcome after deceased donor kidney transplantation . Transplantation 103 ( 2 ): 412 – 419 .
- Weissenbacher , A. , Jara , M. , Ulmer , H. et al. ( 2012 ). Recipient and donor body mass index as important risk factors for delayed kidney graft function . Transplantation 93 ( 5 ): 524 – 529 .
- Jung , G.O. , Yoon , M.R. , Kim , S.J. et al. ( 2010 ). The risk factors of delayed graft function and comparison of clinical outcomes after deceased donor kidney transplantation: single-center study . Transplant. Proc. 42 ( 3 ): 705 – 709 .
- Rosenthal , J.T. , Danovitch , G.M. , Wilkinson , A. , and Ettenger , R.B. ( 1991 ). The high cost of delayed graft function in cadaveric renal transplantation . Transplantation 51 ( 5 ): 1115 – 1118 .
- Orandi , B.J. , James , N.T. , Hall , E.C. et al. ( 2015 ). Center-level variation in the development of delayed graft function after deceased donor kidney transplantation . Transplantation 99 ( 5 ): 997 – 1002 .
- Yarlagadda , S.G. , Coca , S.G. , Formica , R.N. Jr. et al. ( 2009 ). Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis . Nephrol. Dial. Transplant. 24 ( 3 ): 1039 – 1047 .
- Nagaraja , P. , Roberts , G.W. , Stephens , M. et al. ( 2012 ). Influence of delayed graft function and acute rejection on outcomes after kidney transplantation from donors after cardiac death . Transplantation 94 ( 12 ): 1218 – 1223 .
- Singh , R.P. , Farney , A.C. , Rogers , J. et al. ( 2011 ). Kidney transplantation from donation after cardiac death donors: lack of impact of delayed graft function on post-transplant outcomes . Clin. Transplant. 25 ( 2 ): 255 – 264 .
- Saat , T.C. , Susa , D. , Roest , H.P. et al. ( 2014 ). A comparison of inflammatory, cytoprotective and injury gene expression profiles in kidneys from brain death and cardiac death donors . Transplantation 98 ( 1 ): 15 – 21 .
- Lim , W.H. , McDonald , S.P. , Russ , G.R. et al. ( 2017 ). Association between delayed graft function and graft loss in donation after cardiac death kidney transplants-a paired kidney registry analysis . Transplantation 101 ( 6 ): 1139 – 1143 .
- Wu , W.K. , Famure , O. , Li , Y. , and Kim , S.J. ( 2015 ). Delayed graft function and the risk of acute rejection in the modern era of kidney transplantation . Kidney Int. 88 ( 4 ): 851 – 858 .
- Sola , R. , Alarcon , A. , Jimenez , C. , and Osuna , A. ( 2004 ). The influence of delayed graft function . Nephrol. Dial. Transplant. 19 ( Suppl 3 ): iii32 – iii37 .
- Qureshi , F. , Rabb , H. , and Kasiske , B.L. ( 2002 ). Silent acute rejection during prolonged delayed graft function reduces kidney allograft survival . Transplantation 74 ( 10 ): 1400 – 1404 .
- Moreso , F. , Seron , D. , Gil-Vernet , S. et al. ( 1999 ). Donor age and delayed graft function as predictors of renal allograft survival in rejection-free patients . Nephrol. Dial. Transplant. 14 ( 4 ): 930 – 935 .
- Kikic , Z. , Lorenz , M. , Sunder-Plassmann , G. et al. ( 2009 ). Effect of hemodialysis before transplant surgery on renal allograft function–a pair of randomized controlled trials . Transplantation 88 ( 12 ): 1377 – 1385 .
- Shoskes , D.A. and Halloran , P.F. ( 1996 ). Delayed graft function in renal transplantation: etiology, management and long-term significance . J. Urol. 155 ( 6 ): 1831 – 1840 .
- Borobia , A.M. , Romero , I. , Jimenez , C. et al. ( 2009 ). Trough tacrolimus concentrations in the first week after kidney transplantation are related to acute rejection . Ther. Drug Monit. 31 ( 4 ): 436 – 442 .
- Kamar , N. , Garrigue , V. , Karras , A. et al. ( 2006 ). Impact of early or delayed cyclosporine on delayed graft function in renal transplant recipients: a randomized, multicenter study . Am. J. Transplant. 6 ( 5 Pt 1 ): 1042 – 1048 .
- Kuypers , D.R. , de Jonge , H. , Naesens , M. , and Vanrenterghem , Y. ( 2010 ). A prospective, open-label, observational clinical cohort study of the association between delayed renal allograft function, tacrolimus exposure, and CYP3A5 genotype in adult recipients . Clin. Ther. 32 ( 12 ): 2012 – 2023 .
- Hosgood , S.A. and Nicholson , M.L. ( 2018 ). The evolution of donation after circulatory death donor kidney repair in the United Kingdom . Curr. Opin. Organ Transplant. 23 ( 1 ): 130 – 135 .
- Hosgood , S.A. , Thompson , E. , Moore , T. et al. ( 2018 ). Normothermic machine perfusion for the assessment and transplantation of declined human kidneys from donation after circulatory death donors . Br. J. Surg. 105 ( 4 ): 388 – 394 .
- Kotanko , P. , Pusey , C.D. , and Levy , J.B. (1997). Recurrent glomerulonephritis following renal transplantation . Transplantation 63 ( 8 ): 1045 – 1052 .
- Morzycka , M. , Croker , B.P. , Seigler , H.F. , and Ticher , C.C. ( 1982 ). Evaluation of recurrent glomerulonephritis in kidney allografts . AJM 72 ( 4 ): 588 – 598 .
- Allen , P.J. , Chadban , S.J. , Craig , J.C. et al. ( 2017 ). Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes . Kidney Int. 92 ( 2 ): 461 – 469 .
- Abbott , K.C. , Sawyers , E.S. , Oliver , J.D. 3rd et al. ( 2001 ). Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States . Am. J. Kidney Dis. 37 ( 2 ): 366 – 373 .
- Baum , M.A. , Ho , M. , Stablein , D. et al. ( 2002 ). Outcome of renal transplantation in adolescents with focal segmental glomerulosclerosis . Pediatr. Transplant. 6 ( 6 ): 488 – 492 .
- Francis , A. , Trnka , P. , and McTaggart , S.J. ( 2016 ). Long-term outcome of kidney transplantation in recipients with focal segmental glomerulosclerosis . Clin. J. Am. Soc. Nephrol. 11 ( 11 ): 2041 – 2046 .
- Savin , V.J. , Sharma , R. , Sharma , M. et al. ( 1996 ). Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis . N. Engl. J. Med. 334 ( 14 ): 878 – 883 .
- Winn , M.P. ( 2003 ). Approach to the evaluation of heritable diseases and update on familial focal segmental glomerulosclerosis . Nephrol. Dial. Transplant. 18 ( Suppl 6 ): vi14 – vi20 .
- Dantal , J. , Baatard , R. , Hourmant , M. et al. ( 1991 ). Recurrent nephrotic syndrome following renal transplantation in patients with focal glomerulosclerosis. A one-center study of plasma exchange effects . Transplantation 52 ( 5 ): 827 – 831 .
- Cochat , P. , Kassir , A. , Colon , S. et al. ( 1993 ). Recurrent nephrotic syndrome after transplantation: early treatment with plasmaphaeresis and cyclophosphamide . Pediatr. Nephrol. 7 ( 1 ): 50 – 54 .
- Yu , C.C. , Fornoni , A. , Weins , A. et al. ( 2013 ). Abatacept in B7-1-positive proteinuric kidney disease . N. Engl. J. Med. 369 ( 25 ): 2416 – 2423 .
- Kristensen , T. , Ivarsen , P. , and Povlsen , J.V. ( 2017 ). Unsuccessful treatment with abatacept in recurrent focal segmental glomerulosclerosis after kidney transplantation . Case Rep. Nephrol. Dial. 7 ( 1 ): 1 – 5 .
- Sethi , S. and Fervenza , F.C. ( 2012 ). Membranoproliferative glomerulonephritis–a new look at an old entity . N. Engl. J. Med. 366 ( 12 ): 1119 – 1131 .
- Alasfar , S. , Carter-Monroe , N. , Rosenberg , A.Z. et al. ( 2016 ). Membranoproliferative glomerulonephritis recurrence after kidney transplantation: using the new classification . BMC Nephrol. 17 : 7 .
- Briganti , E.M. , Russ , G.R. , McNeil , J.J. et al. ( 2002 ). Risk of renal allograft loss from recurrent glomerulonephritis . N. Engl. J. Med. 347 ( 2 ): 103 – 109 .
- Green , H. , Rahamimov , R. , Rozen-Zvi , B. et al. ( 2015 ). Recurrent membranoproliferative glomerulonephritis type I after kidney transplantation: a 17-year single-center experience . Transplantation 99 ( 6 ): 1172 – 1177 .
- Welte , T. , Arnold , F. , Kappes , J. et al. ( 2018 ). Treating C3 glomerulopathy with eculizumab . BMC Nephrol. 19 ( 1 ): 7 .
- Muczynski , K.A. ( 1995 ). Plasmapheresis maintained renal function in an allograft with recurrent membranoproliferative glomerulonephritis type I . Am. J. Nephrol. 15 ( 5 ): 446 – 449 .
- Farooqui , M. , Alsaad , K. , Aloudah , N. , and Alhamdan , H. ( 2015 ). Treatment-resistant recurrent membranoproliferative glomerulonephritis in renal allograft responding to rituximab: case report . Transplant. Proc. 47 ( 3 ): 823 – 826 .
- Lien , Y.H. and Scott , K. ( 2000 ). Long-term cyclophosphamide treatment for recurrent type I membranoproliferative glomerulonephritis after transplantation . Am. J. Kidney Dis. 35 ( 3 ): 539 – 543 .
- Golgert , W.A. , Appel , G.B. , and Hariharan , S. ( 2008 ). Recurrent glomerulonephritis after renal transplantation: an unsolved problem . Clin. J. Am. Soc. Nephrol. 3 ( 3 ): 800 – 807 .
- Geetha , D. , Eirin , A. , True , K. et al. ( 2011 ). Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis: a multicenter experience . Transplantation 91 ( 12 ): 1370 – 1375 .
- Gera , M. , Griffin , M.D. , Specks , U. et al. ( 2007 ). Recurrence of ANCA-associated vasculitis following renal transplantation in the modern era of immunosupression . Kidney Int. 71 ( 12 ): 1296 – 1301 .
- Elmedhem , A. , Adu , D. , and Savage , C.O. ( 2003 ). Relapse rate and outcome of ANCA-associated small vessel vasculitis after transplantation . Nephrol. Dial. Transplant. 18 ( 5 ): 1001 – 1004 .
- Nyberg , G. , Blohme , I. , Persson , H. et al. ( 1992 ). Recurrence of SLE in transplanted kidneys: a follow-up transplant biopsy study . Nephrol. Dial. Transplant. 7 ( 11 ): 1116 – 1123 .
- Contreras , G. , Mattiazzi , A. , Guerra , G. et al. ( 2010 ). Recurrence of lupus nephritis after kidney transplantation . J. Am. Soc. Nephrol. 21 ( 1207 ): 1200 – 1207 .
- Goral , S. , Ynares , C. , Shappell , S.B. et al. ( 2003 ). Recurrent lupus nephritis in renal transplant recipients revisited: it is not rare . Transplantation 75 ( 5 ): 651 – 656 .
- Bunnapradist , S. , Chung , P. , Peng , A. et al. ( 2006 ). Outcomes of renal transplantation for recipients with lupus nephritis: analysis of the Organ Procurement and Transplantation Network database . Transplantation 82 ( 5 ): 612 – 618 .
- Zhang , L. , Lee , G. , Liu , X. et al. ( 2016 ). Long-term outcomes of end-stage kidney disease for patients with lupus nephritis . Kidney Int. 89 ( 6 ): 1337 – 1345 .
- Moroni , G. , Tantardini , F. , Gallelli , B. et al. ( 2005 ). The long-term prognosis of renal transplantation in patients with lupus nephritis . Am. J. Kidney Dis. 45 ( 5 ): 903 – 911 .
- Sauter , M. , Schmid , H. , Anders , H.J. et al. ( 2009 ). Loss of a renal graft due to recurrence of anti-GBM disease despite rituximab therapy . Clin. Transplant. 23 ( 1 ): 132 – 136 .
- Tang , W. , McDonald , S.P. , Hawley , C.M. et al. ( 2013 ). Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease . Kidney Int. 83 ( 3 ): 503 – 510 .
- Le Quintrec , M. , Zuber , J. , Moulin , B. et al. ( 2013 ). Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome . Am. J. Transplant. 13 ( 3 ): 663 – 675 .
- Fakhouri , F. , Hourmant , M. , Campistol , J.M. et al. ( 2016 ). Terminal complement inhibitor eculizumab in adult patients with atypical hemolytic uremic syndrome: a single-arm, open-label trial . Am. J. Kidney Dis. 68 ( 1 ): 84 – 93 .
- Alasfar , S. and Alachkar , N. ( 2014 ). Atypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literature . Front. Med. (Lausanne) 1 : 52 .
- Sellier-Leclerc , A.L. , Fremeaux-Bacchi , V. , Dragon-Durey , M.A. et al. ( 2007 ). Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome . J. Am. Soc. Nephrol. 18 ( 8 ): 2392 – 2400 .
- Duineveld , C. , Verhave , J.C. , Berger , S.P. et al. ( 2017 ). Living donor kidney transplantation in atypical hemolytic uremic syndrome: a case series . Am. J. Kidney Dis. 70 ( 6 ): 770 – 777 .
- Cruzado , J.M. , de Cordoba , S.R. , Melilli , E. et al. ( 2009 ). Successful renal transplantation in a patient with atypical hemolytic uremic syndrome carrying mutations in both factor I and MCP . Am. J. Transplant. 9 ( 6 ): 1477 – 1483 .
- Randhawa , P.S. , Finkelstein , S. , Scantlebury , V. et al. ( 1999 ). Human polyoma virus-associated interstitial nephritis in the allograft kidney . Transplantation 67 ( 1 ): 103 – 109 .
- Wiseman , A.C. ( 2009 ). Polyomavirus nephropathy: a current perspective and clinical considerations . Am. J. Kidney Dis. 54 ( 1 ): 131 – 142 .
- Sawinski , D. and Goral , S. ( 2015 ). BK virus infection: an update on diagnosis and treatment . Nephrol. Dial. Transplant. 30 ( 2 ): 209 – 217 .
- Dharnidharka , V.R. , Cherikh , W.S. , and Abbott , K.C. ( 2009 ). An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States . Transplantation 87 ( 7 ): 1019 – 1026 .
- Hirsch , H.H. , Vincenti , F. , Friman , S. et al. ( 2013 ). Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study . Am. J. Transplant. 13 ( 1 ): 136 – 145 .
- Almeras , C. , Vetromile , F. , Garrigue , V. et al. ( 2011 ). Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients . Transpl. Infect. Dis. 13 ( 2 ): 101 – 108 .
- Koukoulaki , M. , Grispou , E. , Pistolas , D. et al. ( 2009 ). Prospective monitoring of BK virus replication in renal transplant recipients . Transpl. Infect. Dis. 11 ( 1 ): 1 – 10 .
- Thakur , R. , Arora , S. , Nada , R. et al. ( 2011 ). Prospective monitoring of BK virus reactivation in renal transplant recipients in North India . Transpl. Infect. Dis. 13 ( 6 ): 575 – 583 .
- Singh , H.K. , Andreoni , K.A. , Madden , V. et al. ( 2009 ). Presence of urinary Haufen accurately predicts polyomavirus nephropathy . J. Am. Soc. Nephrol. 20 ( 2 ): 416 – 427 .
- Nickeleit , V. , Klimkait , T. , Binet , I.F. et al. ( 2000 ). Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy . N. Engl. J. Med. 342 ( 18 ): 1309 – 1315 .
- Kuppachi , S. , Thomas , B. , and Kokko , K.E. ( 2013 ). BK virus in the kidney transplant patient . Am. J. Med. Sci. 345 ( 6 ): 482 – 488 .
- Hirsch , H.H. , Randhawa , P. , and AST Infectious Diseases Community of Practice ( 2013 ). BK polyomavirus in solid organ transplantation . Am. J. Transplant. 13 ( Suppl 4 ): 179 – 188 .
- Drachenberg , R.C. , Drachenberg , C.B. , Papadimitriou , J.C. et al. ( 2001 ). Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology . Am. J. Transplant. 1 ( 4 ): 373 – 381 .
- Masutani , K. , Shapiro , R. , Basu , A. et al. ( 2012 ). The Banff 2009 Working Proposal for polyomavirus nephropathy: a critical evaluation of its utility as a determinant of clinical outcome . Am. J. Transplant. 12 ( 4 ): 907 – 918 .
- Sawinski , D. , Forde , K.A. , Trofe-Clark , J. et al. ( 2015 ). Persistent BK viremia does not increase intermediate-term graft loss but is associated with de novo donor-specific antibodies . J. Am. Soc. Nephrol. 26 ( 4 ): 966 – 975 .
- Hirsch , H.H. , Knowles , W. , Dickenmann , M. et al. ( 2002 ). Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients . N. Engl. J. Med. 347 ( 7 ): 488 – 496 .
- Hardinger , K.L. , Koch , M.J. , Bohl , D.J. et al. ( 2010 ). BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results . Am. J. Transplant. 10 ( 2 ): 407 – 415 .
- Johnston , O. , Jaswal , D. , Gill , J.S. et al. ( 2010 ). Treatment of polyomavirus infection in kidney transplant recipients: a systematic review . Transplantation 89 ( 9 ): 1057 – 1070 .
